-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Verrica Pharmaceuticals Inc. quarterly Revenues history and growth rate from Q3 2024 to Q3 2025.
- Verrica Pharmaceuticals Inc. Revenues for the quarter ending September 30, 2025 was $14.3M.